Bropirimine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBropirimine
Drug Alias Name溴匹立明bropiriminabropiriminumbropirimineRemisar +[13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterferon alpha stimulants
TargetsInterferon alpha
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsUrinary Bladder Neoplasms

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG